Lupin
LUPIN · Pharma > Pharmaceuticals & Drugs · Chairman: Manju D Gupta · MD: Nilesh Gupta · Listing date: Sept. 11, 2001 · Employees: 18573 · Mumbai · http://www.lupin.com

Stock Price vs Company Growth
1d
0.9%
1w
2.4%
1m
11.9%
3m
4.7%
6m
6.3%
1y
38.0%
5y
24.4%
10y
3.3%
all
17.7%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun08Sep11Dec14Mar18Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

2,083 0.9%
1,988
2,403
Company Overview

Sales
21,431 Cr
Growth: 14.6%
Profit after Tax
2,626 Cr
Growth: 16.0%
Large Cap
95,036 Cr
P/E: 36.3x
Industry P/E: 33.5x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 21,431
Growth 14.6%
EBITDA 21.5%
P/S 4.4x
Dividend 0.4%
P/E 36.3x
Book Value ₹ 349
PEG Ratio 2.5x
ROE 17.7%
P/B 5.9x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
6.99 %
Hdfc Trustee Company Limited-Hdfc Flexi Cap Fund
4.28 %
Government Pension Fund Global
1.21 %
Franklin India Focused Equity Fund
1.13 %
Icici Prudential Life Insurance Company Limited
1.13 %
Created with Highcharts 8.2.2Sep19Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Jun24
Promoters
Lupin Investments Pvt Ltd
45.3 %
Manju D Gupta
0.85 %
Nilesh D Gupta
0.2 %
Anuja Gupta
0.16 %
Desh Bandhu Gupta Huf
0.14 %
Created with Highcharts 8.2.2Sep19Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Jun24
Others
Rakesh Jhunjhunwala
1.6 %
Nps Trust - A/C Lic Pension Fund Sch-State Govt
1.48 %
Iepf
0.15 %
Created with Highcharts 8.2.2Sep19Dec19Mar20Jun20Sep20Dec20Mar21Sep21Mar22Jun24
Increase    Decrease    No change
Company Profile Detailed

Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.Products and services offered by the companyGlobal FormulationsActive Pharmaceuticals Ingredients (API)BiotechSpecialty BusinessOver The Counter (OTC)Global Manufacturing & Supply ChainAwards2007: Cardinal Health Conferred Two Awards - The ‘Trade Representative Of The Year’ And The ‘Quality Supplier Award’ To Lupin Pharmaceuticals Inc.
Investors (231)
Followers (55)